{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:20:51Z","timestamp":1760574051800,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,14]]},"DOI":"10.7759\/cureus.94605","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:46:52Z","timestamp":1760507212000},"source":"Crossref","is-referenced-by-count":0,"title":["Palliative Radiotherapy for Dysphagia in Esophageal Cancer: Short-Term Benefits and Late Toxicity Risks"],"prefix":"10.7759","author":[{"given":"Shingo","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Koide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamune","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurika","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenori","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tajika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31462-9","article-title":"Oesophageal cancer","volume":"390","author":"Lagergren J","year":"2017","unstructured":"Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017, 390:2383-2396. 10.1016\/S0140-6736(17)31462-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre LA","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015, 65:87-108. 10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7765","article-title":"Controversies in the treatment of local and locally advanced gastric and esophageal cancers","volume":"33","author":"Cohen DJ","year":"2015","unstructured":"Cohen DJ, Leichman L. Controversies in the treatment of local and locally advanced gastric and esophageal cancers. J Clin Oncol. 2015, 33:1754-1759. 10.1200\/JCO.2014.59.7765","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2354.2003.00376.x","article-title":"The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer","volume":"12","author":"Watt E","year":"2003","unstructured":"Watt E, Whyte F. The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer. Eur J Cancer Care. 2003, 12:183-193. 10.1046\/j.1365-2354.2003.00376.x","journal-title":"Eur J Cancer Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005048.pub4","article-title":"Interventions for dysphagia in oesophageal cancer","volume":"2014","author":"Dai Y","year":"2014","unstructured":"Dai Y, Li C, Xie Y, et al.. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014, 2014:CD005048. 10.1002\/14651858.CD005048.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(02)00037-3","article-title":"Endoluminal palliation for dysphagia secondary to esophageal carcinoma","volume":"82","author":"Weigel TL","year":"2002","unstructured":"Weigel TL, Frumiento C, Gaumintz E. Endoluminal palliation for dysphagia secondary to esophageal carcinoma. Surg Clin North Am. 2002, 82:747-761. 10.1016\/S0039-6109(02)00037-3","journal-title":"Surg Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11664","article-title":"Palliative radiotherapy in the local management of stage IVB esophageal cancer: factors affecting swallowing and survival","volume":"37","author":"Suzuki G","year":"2017","unstructured":"Suzuki G, Yamazaki H, Aibe N, et al.. Palliative radiotherapy in the local management of stage IVB esophageal cancer: factors affecting swallowing and survival. Anticancer Res. 2017, 37:3085-3092. 10.21873\/anticanres.11664","journal-title":"Anticancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/02841869609098483","article-title":"Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment","volume":"35","author":"Cwikiel M","year":"1996","unstructured":"Cwikiel M, Cwikiel W, Albertsson M. Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment. Acta Oncol. 1996, 35:75-79. 10.3109\/02841869609098483","journal-title":"Acta Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2224-5820.2013.05.01","article-title":"Palliative concurrent chemoradiotherapy in locally advanced and metastatic esophageal cancer patients with dysphagia","volume":"2","author":"Akl FM","year":"2013","unstructured":"Akl FM, Elsayed-Abd-Alkhalek S, Salah T. Palliative concurrent chemoradiotherapy in locally advanced and metastatic esophageal cancer patients with dysphagia. Ann Palliat Med. 2013, 2:118-123. 10.3978\/j.issn.2224-5820.2013.05.01","journal-title":"Ann Palliat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(00)00225-5","article-title":"A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer","volume":"56","author":"Hayter CRR","year":"2000","unstructured":"Hayter CRR, Huff-Winters C, Paszat L, Youssef YM, Shelley WE, Schulze K. A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. Radiother Oncol. 2000, 56:329-333. 10.1016\/S0167-8140(00)00225-5","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2004.00420.x","article-title":"Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia","volume":"17","author":"Harvey JA","year":"2004","unstructured":"Harvey JA, Bessell JR, Beller E, et al.. Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia. Dis Esophagus. 2004, 17:260-265. 10.1111\/j.1442-2050.2004.00420.x","journal-title":"Dis Esophagus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.23.12.1060","article-title":"Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy","volume":"23","author":"Ogilvie AL","year":"1982","unstructured":"Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982, 23:1060-1067. 10.1136\/gut.23.12.1060","journal-title":"Gut"},{"key":"ref13","article-title":"TNM Classification of Malignant Tumors International Union Against Cancer, 8th Edition","author":"Brierley J","year":"2017","unstructured":"Brierley J, Gospodarowicz MD, Wittekind CT. TNM Classification of Malignant Tumors International Union Against Cancer, 8th Edition. Oxford (ed): Wiley, England; 2017."},{"key":"ref14","unstructured":"CTEP Trial Development and Conduct - NCI. (2017). https.\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm.."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-458. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyr088","article-title":"Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia","volume":"41","author":"Ikeda E","year":"2011","unstructured":"Ikeda E, Kojima T, Kaneko K, et al.. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia. Jpn J Clin Oncol. 2011, 41:964-972. 10.1093\/jjco\/hyr088","journal-title":"Jpn J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003699","article-title":"Risk factors for esophageal fistula associated with chemoradiotherapy for locally advanced unresectable esophageal cancer: a supplementary analysis of JCOG0303","volume":"95","author":"Tsushima T","year":"2016","unstructured":"Tsushima T, Mizusawa J, Sudo K, et al.. Risk factors for esophageal fistula associated with chemoradiotherapy for locally advanced unresectable esophageal cancer: a supplementary analysis of JCOG0303. Medicine. 2016, 95:e3699. 10.1097\/MD.0000000000003699","journal-title":"Medicine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-018-1324-1","article-title":"Palliative radiotherapy and chemoradiotherapy in stage IVA\/B esophageal cancer patients with dysphagia","volume":"23","author":"Kawamoto T","year":"2018","unstructured":"Kawamoto T, Nihei K, Sasai K, Karasawa K. Palliative radiotherapy and chemoradiotherapy in stage IVA\/B esophageal cancer patients with dysphagia. Int J Clin Oncol. 2018, 23:1076-1083. 10.1007\/s10147-018-1324-1","journal-title":"Int J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30363-1","article-title":"Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01)","volume":"3","author":"Penniment MG","year":"2018","unstructured":"Penniment MG, De Ieso PB, Harvey JA, et al.. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Lancet Gastroenterol Hepatol. 2018, 3:114-124. 10.1016\/S2468-1253(17)30363-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7524","article-title":"Palliative radiotherapy versus esophageal stent placement in the management of patients with metastatic esophageal cancer","volume":"18","author":"Martin EJ","year":"2020","unstructured":"Martin EJ, Bruggeman AR, Nalawade VV, Sarkar RR, Qiao EM, Rose BS, Murphy JD. Palliative radiotherapy versus esophageal stent placement in the management of patients with metastatic esophageal cancer. J Natl Compr Canc Netw. 2020, 18:569-574. 10.6004\/jnccn.2019.7524","journal-title":"J Natl Compr Canc Netw"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3747\/co.19.892","article-title":"What is the optimal management of dysphagia in metastatic esophageal cancer?","volume":"19","author":"Hanna WC","year":"2012","unstructured":"Hanna WC, Sudarshan M, Roberge D, et al.. What is the optimal management of dysphagia in metastatic esophageal cancer?. Curr Oncol. 2012, 19:e60-e66. 10.3747\/co.19.892","journal-title":"Curr Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1055\/a-0644-2495","article-title":"Self-expandable metal stent placement for malignant esophageal strictures \u2014 changes in clinical outcomes over time","volume":"51","author":"Reijm AN","year":"2019","unstructured":"Reijm AN, Didden P, Schelling SJ, Siersema PD, Bruno MJ, Spaander MC. Self-expandable metal stent placement for malignant esophageal strictures \u2014 changes in clinical outcomes over time. Endoscopy. 2019, 51:18-29. 10.1055\/a-0644-2495","journal-title":"Endoscopy"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00004-2","article-title":"Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial","volume":"6","author":"Adamson D","year":"2021","unstructured":"Adamson D, Byrne A, Porter C, et al.. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2021, 6:292-303. 10.1016\/S2468-1253(21)00004-2","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401278-palliative-radiotherapy-for-dysphagia-in-esophageal-cancer-short-term-benefits-and-late-toxicity-risks","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:46:54Z","timestamp":1760507214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401278-palliative-radiotherapy-for-dysphagia-in-esophageal-cancer-short-term-benefits-and-late-toxicity-risks"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.94605","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}